secwatch.observer — SEC 8-K summary
======================================

Issuer:     Disc Medicine, Inc. (IRON)
CIK:        0001816736
Form:       8-K
Filed at:   2022-12-28T23:59:59+00:00
Accession:  0001140361-22-047153
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Gemini Therapeutics stockholders approve Disc Medicine merger; closing set for Dec 29
--------------------------------------------------------------------------------

- All five proposals approved, including share issuance (>20% of outstanding), reverse stock split, and compensation.
- Merger expected to close on December 29, 2022, pending remaining closing conditions.
- Reverse stock split at 1-for-10 ratio and reduction of authorized shares to 100 million approved.
- Advisory vote on named executive officer compensation in connection with merger approved (32M for vs 5.2M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816736/000114036122047153/0001140361-22-047153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816736/000114036122047153/brhc10045909_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-047153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer